PET imaging of tau pathology in Alzheimer's disease and tauopathies

Frontiers in Neurology

Volumn 6, Issue MAR, 2015, Pages

  James, Olga G ^a   Doraiswamy, P Murali ^a   Borges Neto, Salvador ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Dementia; PET neuroimaging; Tau pathologies; Tau proteins

Indexed keywords

AMYLOID BETA PROTEIN; AV 1451 F 18; CARBON 11; FDDNP F 18; FLORBETAPIR F 18; FLUTEMETAMOL F 18; TAU PROTEIN; TKH 5105 F 18; TRACER; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DRUG PROTEIN BINDING; DRUG SELECTIVITY; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; MOLECULAR IMAGING; MOLECULAR PATHOLOGY; NEUROPATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROTEIN ASSEMBLY; PROTEIN FUNCTION; TAUOPATHY;

EID: 84926343686     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2015.00038     Document Type: Article

References (15)

1. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement (2013) 9(1):63-75 e2. doi: 10.1016/j.jalz.2012.11.007
2. Thies W, Bleiler L, Alzheimer's A. 2013 Alzheimer's disease facts and figures. Alzheimers Dement (2013) 9(2):208-45. doi:10.1016/j.jalz.2013.02.003
3. Beach TG, Monsell SE, Phillips LE, Kukull W. Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer disease centers, 2005-2010. J Neuropathol Exp Neurol (2012) 71(4):266-73. doi:10.1097/NEN.0b013e31824b211b
4. Jellinger KA, Attems J. Challenges of multimorbidity of the aging brain: a critical update. J Neural Transm (2014). doi:10.1007/s00702-014-1288-x
5. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 7(3):263-9. doi:10.1016/j.jalz.2011.03.005
6. Grundman M, Pontecorvo MJ, Salloway SP, Doraiswamy PM, Fleisher AS, Sadowsky CH, et al. Potential impact of amyloid imaging on diagnosis and intended management in patients with progressive cognitive decline. Alzheimer Dis Assoc Disord (2013) 27(1):4-15. doi:10.1097/WAD.0b013e318279d02a
7. Doraiswamy PM, Sperling RA, Johnson K, Reiman EM, Wong TZ, Sabbagh MN, et al. Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study. Mol Psychiatry (2014) 19(9):1044-51. doi:10.1038/mp.2014.9
8. Iqbal K, Liu F, Gong CX, Grundke-Iqbal I. Tau in Alzheimer disease and related tauopathies. Curr Alzheimer Res (2010) 7(8):656-64. doi:10.2174/156720510793611592
9. Thal DR, Rüb U, Orantes M, Braak H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology (2002) 58(12):1791-800. doi:10.1212/WNL.58.12.1791
10. Braak E, Braak H, Mandelkow EM. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol (1994) 87(6):554-67. doi:10.1007/BF00293315
11. Bancher C, Brunner C, Lassmann H, Budka H, Jellinger K, Wiche G, et al. Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res (1989) 477(1-2):90-9. doi:10.1016/0006-8993(89)91396-6
12. Villemagne VL, Furumoto S, Fodero-Tavoletti MT, Mulligan RS, Hodges J, Harada R, et al. In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease. Eur J Nucl Med Mol Imaging (2014) 41(5):816-26. doi:10.1007/s00259-013-2681-7
13. Okamura N, Furumoto S, Fodero-Tavoletti MT, Mulligan RS, Harada R, Yates P, et al. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET. Brain (2014) 137(Pt 6):1762-71. doi:10.1093/brain/awu064
14. Chien DT, Bahri S, Szardenings AK, Walsh JC, Mu F, Su MY, et al. Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807. J Alzheimers Dis (2013) 34(2):457-68. doi:10.3233/JAD-122059
15. Goedert M, Spillantini MG. Pathogenesis of the tauopathies. J Mol Neurosci (2011) 45(3):425-31. doi:10.1007/s12031-011-9593-4